Clinical Trial Update: Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation [Phase 4]

View source ↗

Summary

This clinical trial update reports results from a Phase 4 study comparing mycophenolate mofetil–based immunosuppression with and without reduced-dose calcineuri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Liver Disease | Phase 4 | Status: COMPLETED | Results posted: 2013-08-02